Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-24 @ 7:24 AM
Study NCT ID:
NCT00004832
Status:
COMPLETED
Last Update Posted:
2015-03-25
First Post:
2000-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
Sponsor:
FDA Office of Orphan Products Development
Organization:
Organization Data
Organization:
Class:
FED
Study ID:
199/13441
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
FED
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |